de Sauvage, Frederic J.
Genentech, Inc,
United States
2024 Rank: 68972
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Developmental Biology
SubField 2:
Immunology
Rank in SubField 1: 1633 out of 149337 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 68972 | 77919 |
| Total Cites | 1987 | 2030 |
| H-index | 21 | 22 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 21 | 21 |
| Number of Single+First+Last Authored Papers | 81 | 81 |
| Total Cites to Single+First+Last Authored Papers | 873 | 878 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1673 | 1701 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.19 |
| Self-Citation Percentage |
2.12%
|
|
de Sauvage, Frederic J.
Genentech, Inc,
United States
2023 Rank: 46778
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Developmental Biology
SubField 2:
Immunology
Rank in SubField 1: 1239 out of 138178 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 46778 | 52819 |
| Total Cites | 2294 | 2351 |
| H-index | 26 | 27 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 33 | 33 |
| Number of Single+First+Last Authored Papers | 79 | 79 |
| Total Cites to Single+First+Last Authored Papers | 1033 | 1048 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1845 | 1883 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.25 |
| Self-Citation Percentage |
2.42%
|
|
de Sauvage, Frederic J.
Genentech Incorporated,
United States
2022 Rank: 39838
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Developmental Biology
SubField 2:
Immunology
Rank in SubField 1: 1221 out of 127685 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 39838 | 46637 |
| Total Cites | 2465 | 2535 |
| H-index | 27 | 27 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 35 | 35 |
| Number of Single+First+Last Authored Papers | 79 | 79 |
| Total Cites to Single+First+Last Authored Papers | 1095 | 1108 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1995 | 2045 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.24 |
| Self-Citation Percentage |
2.76%
|
|
de Sauvage, Frederic J.
Genentech Incorporated,
United States
2020 Rank: 45535
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Developmental Biology
SubField 2:
Immunology
Rank in SubField 1: 1454 out of 105600 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 45535 | 51667 |
| Total Cites | 2794 | 2893 |
| H-index | 29 | 30 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 28 | 28 |
| Number of Single+First+Last Authored Papers | 76 | 76 |
| Total Cites to Single+First+Last Authored Papers | 1242 | 1269 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2219 | 2275 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.27 |
| Self-Citation Percentage |
3.42%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.